£10million funding for hospital aftercare for the homeless

13/5/13: Extract from DoH

It is estimated that currently 70% of homeless people are discharged from hospital back onto the street without their health and housing problems being properly addressed.

The funding pot will support voluntary organisations to work with the NHS and local authorities to create services to ensure that homeless people receive the best possible support and care after leaving hospital.

The £10 million funding will also be used to ensure better intermediate care is available after discharge – vital for recovering from health problems such as TB.

Catch BMJ’s Best Practice Measles modules

Extract from BMJ Best Practice

Best Practice Measles summary

measlesMeasles is an epidemic disease prevalent worldwide whose incidence has been curtailed markedly in countries where immunisation is widespread. It is characterised by cough, coryza, conjunctivitis, a characteristic exanthem, and a pathognomonic enanthem (Koplik spots). Measles is preventable by immunisation, but high levels of coverage are required to prevent outbreaks of disease. Treatment is primarily supportive, and complications of measles are more common in immunocompromised and poorly nourished individuals and include pneumonia, laryngotracheitis, otitis media, and encephalitis.

You can view the Best Practice Prevention information on measles here, or Treatment information here.

Free BMJ Learning Modules on measles!

Following the recent outbreak of measles in the UK, BMJ Learning is offering its modules on the subject for free for one month only!

Measles: an update on diagnosis and management

Childhood immunisation: an update

NICE makes changes to NELM awareness updates

National electronic Library of Medicine

A number of news updates preciously produced by NELM are no longer available, following changes made by NICE NHS Evidence to their subscription service.  The pages shown below have all been affected.  We apologise for the inconvenience but this was outside our control. Work is ongoing to re-establish a new service.

  • Cancer
  • Cardiovascular
  • Community
  • General Medicine
  • Medical Specialties
  • Orthopaedics
  • Rehabilitation
  • Surgery and
  • Women and Children

Currently only email subscriptions are available – see http://www.nice.org.uk/mpc/MedicinesPrescribingAlerts.jsp

Please login with your usual Athens details then complete your subscription choices, indicating your preference for daily or weekly alert service.

DoH: MenC vaccine

In summary, these changes are:

  • the removal of the 2nd dose at age 16 weeks from the routine schedule for infants
  • the introduction of an adolescent booster dose at around 14 years

This resource does not cover the actual administration techniques involved in vaccination against MenC. Information on immunisation by nurses and other health professionals is available from Immunisation against infectious disease, Green Book.

Studies show that vaccination against meningococcal C (MenC) disease in early childhood provides a relatively short-term protective immune response. Protection given by vaccination at 12 months wanes by the teenage years, but vaccination later in childhood provides higher levels of antibody that persist for longer.

This document summarises the changes to the schedule, and addresses likely technical questions about making the changes work in practice.